MARIKO PUSINELLI: Open Payments
NPI 1871203968 · ELMHURST, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,147 in 45 payments from 21 companies in 2025. Trend: 2023 $1,866 · 2024 $1,553 · 2025 $1,147
Food & beverage: $1,147
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $153 |
| Janssen Biotech, Inc. | 5 | $150 |
| Novartis Pharmaceuticals Corporation | 6 | $119 |
| Genentech USA, Inc. | 4 | $108 |
| JAZZ PHARMACEUTICALS INC. | 2 | $73 |
| AstraZeneca Pharmaceuticals LP | 2 | $58 |
| Lilly USA, LLC | 2 | $56 |
| ABBVIE INC. | 2 | $55 |
| BeOne Medicines USA, Inc. | 2 | $55 |
| Gilead Sciences, Inc. | 2 | $43 |
Products named: KEYTRUDA, TECVAYLI, RYBREVANT, Tecentriq, BRUKINSA, KISQALI, LUTATHERA, Trodelvy.
Industry payments across IL — which companies pay providers there.
